Chunying Lu Selected Research

cisatracurium (Nimbex)

1/2017	Altered pharmacodynamics and pharmacokinetics of cisatracurium in patients with severe mitral valve regurgitation during anaesthetic induction period.
1/2016	Altered Cisatracurium Pharmacokinetics and Pharmacodynamics in Patients with Congenital Heart Defects.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunying Lu Research Topics

Disease

2	Infarction (Infarctions) 08/2012 - 01/2012
1	Central Nervous System Diseases (CNS Diseases) 01/2022
1	Coronavirus Infections 01/2022
1	Mitral Valve Insufficiency (Mitral Regurgitation) 01/2017
1	Congenital Heart Defects (Congenital Heart Defect) 01/2016
1	Atrial Heart Septal Defects (Atrial Septal Defect) 01/2016
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 01/2016
1	Fibrosis (Cirrhosis) 08/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2012
1	Reperfusion Injury 01/2012
1	Ischemia 01/2012

Drug/Important Bio-Agent (IBA)

2	Peptides (Polypeptides)IBA 01/2022 - 01/2022
2	cisatracurium (Nimbex)FDA Link 01/2017 - 01/2016
1	Pharmaceutical PreparationsIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 08/2012
1	locked nucleic acidIBA 01/2012
1	Caspase 3 (Caspase-3)IBA 01/2012
1	OligonucleotidesIBA 01/2012

Therapy/Procedure

1	Ligation 08/2012